| Dobrita Family Care Llc | |
|
46 W Avon Rd Suite 301 Avon CT 06001-3679 | |
| (860) 839-6333 | |
| Not Available |
| Full Name | Dobrita Family Care Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 46 W Avon Rd, Avon, Connecticut |
| Authorized Official Name and Position | Alina Dobrita (PHYSICIAN, MEMBER) |
| Authorized Official Contact | 8608396333 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dobrita Family Care Llc 46 W Avon Rd Suite 301 Avon CT 06001-3679 Ph: (860) 839-6333 | Dobrita Family Care Llc 46 W Avon Rd Suite 301 Avon CT 06001-3679 Ph: (860) 839-6333 |
| NPI Number | 1457896862 |
|---|---|
| Provider Enumeration Date | 12/21/2016 |
| Last Update Date | 12/21/2016 |
| Medicare PECOS PAC ID | 6204113210 |
|---|---|
| Medicare Enrollment ID | O20170501000025 |
News Archive
All soccer players and fans know that it is better to win than to lose. Yet the fact that victory also means less risk of injury is not as obvious. New findings from researchers in sports medicine at Linköping University have aroused great interest among Europe's elite soccer teams.
Injections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA.
The American Academy of Pain Medicine is pleased to announce its 2015 Pain Medicine Fellowship Excellence Award Recipients in recognition of a Pain Medicine Fellowship Program that provides an exceptional learning experience to its fellows, preparing them to deliver the highest standard of care to patients with pain.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457896862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 045219 (Connecticut) | Primary |
| Provider Name | Lani F Ralston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699862912 PECOS PAC ID: 0840292025 Enrollment ID: I20070201000453 |
News Archive
All soccer players and fans know that it is better to win than to lose. Yet the fact that victory also means less risk of injury is not as obvious. New findings from researchers in sports medicine at Linköping University have aroused great interest among Europe's elite soccer teams.
Injections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA.
The American Academy of Pain Medicine is pleased to announce its 2015 Pain Medicine Fellowship Excellence Award Recipients in recognition of a Pain Medicine Fellowship Program that provides an exceptional learning experience to its fellows, preparing them to deliver the highest standard of care to patients with pain.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 2 days ago
| Provider Name | Alina I Dobrita |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194945063 PECOS PAC ID: 4082713847 Enrollment ID: I20070620000483 |
News Archive
All soccer players and fans know that it is better to win than to lose. Yet the fact that victory also means less risk of injury is not as obvious. New findings from researchers in sports medicine at Linköping University have aroused great interest among Europe's elite soccer teams.
Injections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA.
The American Academy of Pain Medicine is pleased to announce its 2015 Pain Medicine Fellowship Excellence Award Recipients in recognition of a Pain Medicine Fellowship Program that provides an exceptional learning experience to its fellows, preparing them to deliver the highest standard of care to patients with pain.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 2 days ago
News Archive
All soccer players and fans know that it is better to win than to lose. Yet the fact that victory also means less risk of injury is not as obvious. New findings from researchers in sports medicine at Linköping University have aroused great interest among Europe's elite soccer teams.
Injections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA.
The American Academy of Pain Medicine is pleased to announce its 2015 Pain Medicine Fellowship Excellence Award Recipients in recognition of a Pain Medicine Fellowship Program that provides an exceptional learning experience to its fellows, preparing them to deliver the highest standard of care to patients with pain.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 2 days ago
Avon Medical Group, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 W Avon Rd, Lowr Level, Avon, CT 06001 Phone: 860-673-2581 Fax: 860-675-6202 | |
Pourkavoos Medical Center, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 35 Nod Rd, Suite 205, Avon, CT 06001 Phone: 860-676-0090 Fax: 860-676-0040 | |
Natural Health And Healing, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12 W Main St, Avon, CT 06001 Phone: 860-677-4600 Fax: 860-677-4660 | |
Jm Medical Consulting Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 Westmont Rd, Avon, CT 06001 Phone: 860-550-1995 | |
Avon Family Health, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 W Avon Rd, Suite D, Avon, CT 06001 Phone: 860-675-6595 Fax: 860-673-6721 | |
Dartmouth Endocrinology, Diabetes And Metabolism, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 44 Dale Rd Ste 201, Avon, CT 06001 Phone: 860-679-0234 Fax: 860-606-0060 |